SCHEMBL5456914

SCHEMBL5456914

N#Cc1cccnc1NC(=O)N1CC=C(c2ccc(NC(=O)Nc3ccccc3F)cc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
MAPT P10636 3/20 0.48
NPC1 O15118 2/20 0.48
ALOX15 P16050 2/20 0.48
RAB9A P51151 2/20 0.48
HPGD P15428 1/20 0.48
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
NAMPT P43490 10/20 0.46
TRPV1 Q8NER1 3/20 0.46
TSHR P16473 1/20 0.45
PIK3CD O00329 1/20 0.44
PIK3R1 P27986 1/20 0.44
PIK3CA P42336 1/20 0.44
PIK3CB P42338 1/20 0.44
MTOR P42345 1/20 0.44
PIK3CG P48736 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5458381 0.88 NAMPT (0.48) ALDH1A1SMN1; SMN2MAPTNPC1ALOX15
SCHEMBL5461007 0.87 RAB9A (0.51) ALDH1A1SMN1; SMN2MAPTNPC1ALOX15
SCHEMBL5469430 0.83 NAMPT (0.47) ALDH1A1SMN1; SMN2MAPTNPC1ALOX15
SCHEMBL5454328 0.83 IDO1 (0.46) ALDH1A1SMN1; SMN2MAPTRAB9ACASP3
SCHEMBL5465544 0.82 NPC1 (0.55) ALDH1A1SMN1; SMN2MAPTNPC1ALOX15
SCHEMBL5460036 0.81 PANK3 (0.41) ALDH1A1SMN1; SMN2MAPTNPC1RAB9A
SCHEMBL5463378 0.78 NPC1 (0.58) ALDH1A1SMN1; SMN2MAPTNPC1ALOX15
SCHEMBL5460127 0.76 MAPT (0.47) ALDH1A1SMN1; SMN2MAPTNPC1ALOX15
SCHEMBL5473690 0.76 GFER (0.60) ALDH1A1SMN1; SMN2MAPTNPC1ALOX15
SCHEMBL5460590 0.73 MAPT (0.52) ALDH1A1SMN1; SMN2MAPTNPC1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 ALDH1A1 731/4885SMN1; SMN2 4424/4885MAPT 758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.